Cargando…

Editorial: Paradigm Changes are Required in HIV Vaccine Research

Detalles Bibliográficos
Autor principal:	Van Regenmortel, Marc H. V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4477177/ https://www.ncbi.nlm.nih.gov/pubmed/26157442 http://dx.doi.org/10.3389/fimmu.2015.00326

Ejemplares similares

Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design
por: Van Regenmortel, Marc H. V.
Publicado: (2018)

An Outdated Notion of Antibody Specificity is One of the Major Detrimental Assumptions of the Structure-Based Reverse Vaccinology Paradigm, Which Prevented It from Helping to Develop an Effective HIV-1 Vaccine
por: Van Regenmortel, Marc H. V.
Publicado: (2014)

Basic research in HIV vaccinology is hampered by reductionist thinking
por: Van Regenmortel, Marc H. V.
Publicado: (2012)

More Surprises in the Development of an HIV Vaccine
por: Esparza, José, et al.
Publicado: (2014)

Commentary: Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking
por: Van Regenmortel, Marc H. V.
Publicado: (2016)

Requirements for Empirical Immunogenicity Trials, Rather than Structure-Based Design, for Developing an Effective HIV Vaccine
por: Van Regenmortel, Marc H V
Publicado: (2019)

Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine
por: Van Regenmortel, Marc H. V.
Publicado: (2011)

A New Scientific Paradigm may be Needed to Finally Develop an HIV Vaccine
por: Esparza, José
Publicado: (2015)

Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?
por: Van Regenmortel, Marc H V
Publicado: (2015)

Editorial: Advances in T Cell Therapeutic Vaccines for HIV
por: Macatangay, Bernard J. C., et al.
Publicado: (2022)

Editorial: Parasites in the Tropic—A New Paradigm Shift
por: Nissapatorn, Veeranoot, et al.
Publicado: (2017)

Editorial: Research, Development and Clinical Trials for Peptide-Based Vaccines
por: Jiang, Shisong, et al.
Publicado: (2022)

Challenges in HIV Vaccine Research for Treatment and Prevention
por: Ensoli, Barbara, et al.
Publicado: (2014)

Editorial: Frontiers’ Research Topic “Cancer Vaccines: Time to Think Differently!”
por: McArdle, Stephanie E. B., et al.
Publicado: (2021)

Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19
por: Gong, Wenping, et al.
Publicado: (2023)

Editorial: Immunological Memory to Fungal Infections and Vaccine Development
por: Nicola, André Moraes, et al.
Publicado: (2022)

Editorial: Mucosal immunity to HIV and SARS-CoV-2 infection and vaccination
por: Bomsel, Morgane, et al.
Publicado: (2023)

Structure-Based Reverse Vaccinology Failed in the Case of HIV Because it Disregarded Accepted Immunological Theory
por: Van Regenmortel, Marc H. V.
Publicado: (2016)

Editorial: Immunology of HPV Infection and Vaccination: Progress and Challenges
por: Licciardi, Paul V., et al.
Publicado: (2021)

Editorial: Why Vaccines to HIV, HCV, and Malaria Have So Far Failed—Challenges to Developing Vaccines Against Immunoregulating Pathogens
por: Li, Shuo, et al.
Publicado: (2015)

Editorial: History of Chemoattractant Research
por: Moser, Bernhard
Publicado: (2015)

Epigenomics and Early Life Human Humoral Immunity: Novel Paradigms and Research Opportunities
por: Gutierrez, Maria J., et al.
Publicado: (2020)

Editorial: Vaccines and Immunostimulants for Finfish
por: Munang'andu, Hetron M., et al.
Publicado: (2020)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

Editorial: HIV-Associated Immune Activation and Persistent Inflammation
por: Hoenigl, Martin, et al.
Publicado: (2019)

Editorial: Approaches to Advance Cancer Vaccines to Clinical Utility
por: Van Nuffel, An M. T., et al.
Publicado: (2019)

Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015)

Editorial: Trained Immunity-Based Vaccines
por: Subiza, Jose Luis, et al.
Publicado: (2021)

Editorial: Immunological aspects of vaccine safety
por: Vajdy, Michael, et al.
Publicado: (2023)

Editorial: Irradiation technologies for vaccine development
por: Wijewardana, Viskam, et al.
Publicado: (2023)

Editorial: Innate immune responses in HIV controllers
por: Thobakgale, Christina, et al.
Publicado: (2023)

The Frontiers Publishing Paradigm
por: Smith, Kendall A.
Publicado: (2012)

Editorial: HIV-Induced Damage of B Cells and Production of HIV Neutralizing Antibodies
por: Chiodi, Francesca, et al.
Publicado: (2018)

Editorial: Oral Immune-Enhancing Research in Fish
por: Galindo-Villegas, Jorge, et al.
Publicado: (2022)

Editorial: Cancer Prevention: Targeting Premalignant Epithelial Neoplasms in the Era of Cancer Immunotherapy and Vaccines
por: Çuburu, Nicolas, et al.
Publicado: (2022)

Editorial: Reassessing Twenty Years of Vaccine Development against Tuberculosis
por: Schaible, Ulrich E., et al.
Publicado: (2018)

Editorial: The Schistosomiasis Vaccine – It is Time to Stand up
por: El Ridi, Rashika, et al.
Publicado: (2015)

Editorial: Epitope Discovery and Synthetic Vaccine Design
por: Palatnik-de-Sousa, Clarisa Beatriz, et al.
Publicado: (2018)

Editorial: Novel Strategies for Anti-Tumor Vaccines
por: Accolla, Roberto S., et al.
Publicado: (2020)

Editorial: Nanoparticle Vaccines Against Infectious Diseases
por: Reljic, Rajko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_svtubf3v2gpn2qejcht54k8t6i